Table 2.
Number of MS patients improved after SCS according to the evaluated function.
| Function | Improvement (yes/no) | p |
|---|---|---|
| All patients | ||
| Motor disorders | 193/153 | |
| Urinary dysfunction | 90/44 | p = 0.0144 |
| Neuropathic pain | 28/6 | p = 0.0030 |
|
| ||
| Patients submitted to the trial and then implanted | ||
| Motor disorders | 158/121 | |
| Urinary dysfunction | 40/17 | p = 0.038 |
| Neuropathic pain | 15/4 | p = 0.044 |
|
| ||
| Patients with de novo implantation | ||
| Motor disorders | 35/32 | |
| Urinary dysfunction | 50/27 | n.s |
| Neuropathic pain | 13/2 | p = 0.0126 |